Eneda Toska

5.3k total citations
36 papers, 1.1k citations indexed

About

Eneda Toska is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Eneda Toska has authored 36 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Eneda Toska's work include Epigenetics and DNA Methylation (8 papers), PI3K/AKT/mTOR signaling in cancer (8 papers) and Renal and related cancers (6 papers). Eneda Toska is often cited by papers focused on Epigenetics and DNA Methylation (8 papers), PI3K/AKT/mTOR signaling in cancer (8 papers) and Renal and related cancers (6 papers). Eneda Toska collaborates with scholars based in United States, United Kingdom and Spain. Eneda Toska's co-authors include Maurizio Scaltriti, Stefan G. E. Roberts, Pau Castel, José Baselga, Jeffrey A. Engelman, Maura N. Dickler, Christina S. Leslie, Carmen Chan, Kathryn F. Medler and Hatice U. Osmanbeyoglu and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Eneda Toska

34 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eneda Toska United States 17 855 263 227 210 122 36 1.1k
Pau Castel United States 13 801 0.9× 319 1.2× 195 0.9× 153 0.7× 80 0.7× 39 1.1k
Cheguo Cai China 15 663 0.8× 442 1.7× 147 0.6× 230 1.1× 118 1.0× 38 1.1k
Cindy Hodakoski United States 10 864 1.0× 203 0.8× 113 0.5× 315 1.5× 56 0.5× 11 1.2k
Binoj C. Nair United States 17 633 0.7× 241 0.9× 107 0.5× 168 0.8× 250 2.0× 30 921
Rachel Bikoff United States 5 865 1.0× 247 0.9× 315 1.4× 334 1.6× 82 0.7× 7 1.3k
Michal Grzmil Switzerland 20 834 1.0× 144 0.5× 166 0.7× 187 0.9× 87 0.7× 32 1.2k
Jaya Sangodkar United States 19 1.0k 1.2× 243 0.9× 101 0.4× 200 1.0× 101 0.8× 24 1.3k
Tim P. Green United Kingdom 13 699 0.8× 504 1.9× 159 0.7× 133 0.6× 109 0.9× 14 1.2k
Rumey C. Ishizawar United States 8 600 0.7× 436 1.7× 170 0.7× 111 0.5× 66 0.5× 13 1.1k
Yu-Mei Feng China 21 847 1.0× 466 1.8× 146 0.6× 383 1.8× 83 0.7× 41 1.3k

Countries citing papers authored by Eneda Toska

Since Specialization
Citations

This map shows the geographic impact of Eneda Toska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eneda Toska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eneda Toska more than expected).

Fields of papers citing papers by Eneda Toska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eneda Toska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eneda Toska. The network helps show where Eneda Toska may publish in the future.

Co-authorship network of co-authors of Eneda Toska

This figure shows the co-authorship network connecting the top 25 collaborators of Eneda Toska. A scholar is included among the top collaborators of Eneda Toska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eneda Toska. Eneda Toska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jagirdar, Kasturee, W. Marston Linehan, Vito W. Rebecca, et al.. (2025). TFE3 fusion oncoprotein condensates drive transcriptional reprogramming and cancer progression in translocation renal cell carcinoma. Cell Reports. 44(4). 115539–115539. 1 indexed citations
2.
Cai, Yanyan, Fan Wu, HuiYong Zhao, et al.. (2025). Inhibition of NR2F2 restores hormone therapy response to endocrine refractory breast cancers. Science Translational Medicine. 17(801). eadk7786–eadk7786. 2 indexed citations
3.
Olsen, Sarah Naomi, Charlie Hatton, Zhengtao Chu, et al.. (2025). Combined inhibition of KAT6A/B and Menin reverses estrogen receptor-driven gene expression programs in breast cancer. Cell Reports Medicine. 6(7). 102192–102192. 1 indexed citations
4.
Toska, Eneda. (2024). Epigenetic mechanisms of cancer progression and therapy resistance in estrogen-receptor (ER+) breast cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1879(3). 189097–189097. 5 indexed citations
5.
Toska, Eneda, et al.. (2024). Mutant ARID1A: igniting cancer immunotherapy. Trends in Immunology. 45(8). 565–567. 2 indexed citations
6.
Arruabarrena-Aristorena, Amaia & Eneda Toska. (2022). Epigenetic Mechanisms Influencing Therapeutic Response in Breast Cancer. Frontiers in Oncology. 12. 924808–924808. 5 indexed citations
7.
Sherrard, Alice, et al.. (2021). Cholesterol is required for transcriptional repression by BASP1. Proceedings of the National Academy of Sciences. 118(29). 17 indexed citations
8.
Wolfe, Andrew L., Qingwen Zhou, Eneda Toska, et al.. (2021). UDP-glucose pyrophosphorylase 2, a regulator of glycogen synthesis and glycosylation, is critical for pancreatic cancer growth. Proceedings of the National Academy of Sciences. 118(31). 35 indexed citations
9.
Castel, Pau, Eneda Toska, Jeffrey A. Engelman, & Maurizio Scaltriti. (2021). The present and future of PI3K inhibitors for cancer therapy. Nature Cancer. 2(6). 587–597. 128 indexed citations
10.
Toska, Eneda, Pau Castel, Sagar Chhangawala, et al.. (2019). PI3K Inhibition Activates SGK1 via a Feedback Loop to Promote Chromatin-Based Regulation of ER-Dependent Gene Expression. Cell Reports. 27(1). 294–306.e5. 50 indexed citations
11.
Toska, Eneda, et al.. (2019). Overview of the relevance of PI3K pathway in HR-positive breast cancer. Annals of Oncology. 30(Suppl_10). x3–x11. 119 indexed citations
12.
Mondello, Patrizia, Elliott J. Brea, Elisa de Stanchina, et al.. (2017). Panobinostat acts synergistically with ibrutinib in diffuse large B cell lymphoma cells with MyD88 L265 mutations. JCI Insight. 2(6). e90196–e90196. 35 indexed citations
13.
Osmanbeyoglu, Hatice U., Eneda Toska, Carmen Chan, José Baselga, & Christina S. Leslie. (2017). Pancancer modelling predicts the context-specific impact of somatic mutations on transcriptional programs. Nature Communications. 8(1). 14249–14249. 27 indexed citations
14.
Castel, Pau, Haley Ellis, Ružica Bago, et al.. (2016). PDK1-SGK1 Signaling Sustains AKT-Independent mTORC1 Activation and Confers Resistance to PI3Kα Inhibition. Cancer Cell. 30(2). 229–242. 173 indexed citations
15.
Busch, Maike, Manfred Beier, Paul J. Romaniuk, et al.. (2014). Classification of a frameshift/extended and a stop mutation in WT1 as gain-of-function mutations that activate cell cycle genes and promote Wilms tumour cell proliferation. Human Molecular Genetics. 23(15). 3958–3974. 13 indexed citations
16.
Tsakogiannis, D., et al.. (2014). Multiplex PCR assay for the rapid identification of human papillomavirus genotypes 16, 18, 45, 35, 66, 33, 51, 58, and 31 in clinical samples. Archives of Virology. 160(1). 207–214. 16 indexed citations
17.
Tsakogiannis, D., Eneda Toska, Zaharoula Kyriakopoulou, et al.. (2014). Duplex Real-time PCR assay and SYBR green I melting curve analysis for molecular identification of HPV genotypes 16, 18, 31, 35, 51 and 66. Molecular and Cellular Probes. 29(1). 13–18. 7 indexed citations
18.
Iacobucci, Gary J., et al.. (2013). Presenilin influences glycogen synthase kinase-3 β (GSK-3β) for kinesin-1 and dynein function during axonal transport. Human Molecular Genetics. 23(5). 1121–1133. 41 indexed citations
19.
Toska, Eneda, Jayasha Shandilya, Sarah J. Goodfellow, Kathryn F. Medler, & Stefan G. E. Roberts. (2013). Prohibitin is required for transcriptional repression by the WT1–BASP1 complex. Oncogene. 33(43). 5100–5108. 29 indexed citations
20.
Toska, Eneda, Jayasha Shandilya, Sarah J. Goodfellow, et al.. (2012). Repression of Transcription by WT1-BASP1 Requires the Myristoylation of BASP1 and the PIP2-Dependent Recruitment of Histone Deacetylase. Cell Reports. 2(3). 462–469. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pau Castel Breakdown of academic impact, for papers by Cheguo Cai Breakdown of academic impact, for papers by Cindy Hodakoski Breakdown of academic impact, for papers by Binoj C. Nair Breakdown of academic impact, for papers by Rachel Bikoff Breakdown of academic impact, for papers by Michal Grzmil Breakdown of academic impact, for papers by Jaya Sangodkar Breakdown of academic impact, for papers by Tim P. Green Breakdown of academic impact, for papers by Rumey C. Ishizawar Breakdown of academic impact, for papers by Yu-Mei Feng
Rankless by CCL
2026